Open AccessDistinct mechanisms of hypoglycaemia in patients with somatostatin‐secreting neuroendocrine tumours
Author(s) -
Wiesli Peter,
Pavlicek Vojtech,
Brändle Michael,
Pfammatter Thomas,
Perren Aurel,
Schmid Christoph
Publication year - 2019
Publication title -
endocrinology, diabetes and metabolism
Language(s) - English
Resource type - Journals
ISSN - 2398-9238
DOI - 10.1002/edm2.83
Subject(s) - somatostatin , medicine , octreotide , scintigraphy , endocrinology , hyperplasia , pancreas , neuroendocrine tumors , biopsy , gastroenterology
Somatostatin‐secreting neuroendocrine tumours may present with diabetes, cholelithiasis and steatorrhoea. In addition, hypoglycaemia has been associated with somatostatinomas. However, the mechanism of hypoglycaemia in patients with somatostatinomas has not been well characterized. Methods We describe two patients with recurrent neuroglycopenic episodes caused by somatostatin‐secreting neuroendocrine tumours in the liver, detected by abdominal CTs and whole‐body octreotide scintigraphy scans and confirmed by biopsy. Results Pancreatic islet hyperplasia and co‐secretion of insulin (in addition to somatostatin) from tumour cells, respectively, have been characterized as completely distinct mechanisms of hypoglycaemia at both the functional and morphological levels in these two patients. Conclusions Hypoglycaemia may be caused by different mechanisms in patients with somatostatinomas.